Prediction of distribution coefficient from structure. 1. Estimation method

Journal of Pharmaceutical Sciences

Volumn 86, Issue 7, 1997, Pages 865-871

  Csizmadia, Ferenc ^a,d   Tsantili Kakoulidou, Anna ^b   Panderi, Irene ^b   Darvas, Ferenc ^c  

^a CompuDrug Chemistry Ltd ^*  (Hungary)

^b UNIVERSITY OF ATHENS   (Greece)

^c Comgenex Inc ^*  (Hungary)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DICHLOROPHENOXYACETIC ACID; 2,4,5 TRICHLOROPHENOXYACETIC ACID; ACETIC ACID DERIVATIVE; AMINE; AMINO ACID; AMPHOLYTE; ANILINE DERIVATIVE; BUTYRIC ACID DERIVATIVE; CHLORPROMAZINE; DICAMBA; DIPEPTIDE; ION; KETOPROFEN; MEFENAMIC ACID; NITROPHENOL; PHENYLACETIC ACID DERIVATIVE; PROMAZINE; PROPIONIC ACID DERIVATIVE; PROPRANOLOL; SARCOSINE; TRIFLUPROMAZINE; TRIMETHOPRIM; TRIPEPTIDE;

ARTICLE; DRUG DISTRIBUTION; DRUG STRUCTURE; PARTITION COEFFICIENT; PREDICTION; PROTON TRANSPORT; THEORY;

EID: 0030788112     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960177k     Document Type: Article

References (57)

1. van de Waterbeemd, H.; Testa, B. Adv. Drug Res. 1987, 16, 85.
2. Kubinyi, H. Prog. Drug Res., 1979, 23, 97.
3. Hansch, C. In Biological Activity and Chemical Structure; Keverling Buisman, J. A., Ed.; Elsevier: Amsterdam, 1977.
4. Mayer, J.; van de Waterbeemd, H. Environ. Health Perspect. 1985, 61, 295-306.
5. van Gestel, C. A. M.; Wei-Chun Ma, Smit, C. E. In QSAR in Environmental Toxicology; Hermens, J. L. M., Opperhuizen, A., Eds.; Elsevier: Amsterdam, 1990; pp 589-604.
6. Walter, H.; Brooks, D. E.; Fisher, D. Partitioning in Aqueous Two Phase Systems; Academic Press: London, 1985.
7. Leo, A. J.; Hansch, C.; Elkins, D. Chem. Rev. 1971, 7, 525-616.
8. Barbato, F.; Caliendo, G.; La Rotonda, M. L; Silipo, C.; Toraldo, G., Vittoria, A. Quant. Struct. - Act. Relat. 1986, 5, 88-95.
9. Leo, A. In Comprehensive Medicinal Chemistry; Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press: Oxford, 1990; Vol. IV, pp 295-319.
10. Rekker, R. F.; Mannhold, R. Calculation of Drug Lipophilicity; VCH: Weinheim, 1992.
11. Chose, A. K.; Grippen, G. M. J. Comput. Chem. 1986, 7, 565-577.
12. Broto, P.; Moreau, G.; Vandycke, C. Eur. J. Med. Chem.-Chim. Ther. 1984, 19, 71-78.
13. PrologD 2.1, 1997, CompuDrug Chemistry Ltd., 1362 Budapest 62, P.O.B. 405, Hungary.
14. Tsantili-Kakoulidou, A.; Panderi, I; Piperaki, S.; Csizmadia, F; Darvas, F. Eur. J. Drug Metabol. Pharmacokinet. In press.
15. Parang, K.; Knaus, E. E.; Wiebe, L. L; Sardari, S.; Daneshtalab, M; Csizmadia, F. Arch. Pharm. Pharm. Med. Chem. 1996, 329, 475-482.
16. Pallas for Windows 2.0, 1997, CompuDrug Chemistry Ltd., 1362 Budapest 62, P.O.B. 405, Hungary.
17. van de Graaf, B.; Hoefnagel, A. J.; Wepster, B. M. J. Org. Chem. 1981, 46, 653-657.
18. Noszál, B. J. Phys. Chem. 1986, 90, 4104-4110.
19. Noszál, B. J. Phys. Chem. 1986, 90, 6345-6349.
20. Takács-Novák, K.; Noszál, B.; Hermecz, I.; Keresztúri, G.; Podányi, B.; Szász, Gy. J. Pharm. Sci. 1990, 79, 1023-1028.
21. Takács-Novák, K.; Józan, M.; Hermecz, I.; Szász, Gy. Int. J. Pharm. 1992, 79, 89-96.
22. Takács-Novák, K.; Avdeef, A.; Box, K. J.; Podányi, B.; Szász, Gy. J. Pharm. Biomed. Anal. 1994, 12, 1369-1377.
23. Takács-Novák, K.; Józan, M.; Szász, Gy. Int. J. Pharm. 1995, 113, 47-55
24. Avdeef, A. In Lipohilicity in Drug Action and Toxicology; Pliska V., Testa, B., van de Waterbeemd, H., Eds., VCH: Weinheim, 1995; pp 109-139.
25. pKalc 3.2, 1996, CompuDrug Chemistry Ltd., 1362 Budapest 62, P.O.B. 405, Hungary.
26. Csizmadia, F.; Szegezdi, J.; Darvas, F. In Proceedings of the 9th European Symposium on Structure-Activity Relationships: QSAR and Molecular Modelling, September 7-11, 1992; Wermuth, C. G., Eds.; ESCOM: Leiden, 1993; pp 507-510.
27. a, Prediction for Organic Acids and Bases; Chapman and Hall: London, 1981.
28. PrologP 5.1, 1995, CompuDrug Chemistry Ltd., 1362 Budapest 62, P.O.B. 405, Hungary.
29. Rekker, R. F.; de Kort, H. M.; Eur. J. Med. Chem. 1979, 14, 479-488.
30. Viswandadhan, V. N.; Ghose, A. K.; Revankar, G. R.; Robins, R. K. J. Chem. Inf. Comput. Sci. 1989, 29, 163-172.
31. Schwarzenbach, R. P.; Stierli, R.; Folsom, B. R.; Zeyer, J. Environ. Sci. Technol. 1988, 22, 83-92.
32. Jafvert, C. T.; Westall, J. C.; Grieder, E.; Schwarzenbach, R. P. Environ. Sci. Technol. 1990, 24, 1795-1803. Experimental data applied in this paper was provided by J. Westall.
33. Murthy, K. S.; Zografi, G. J. Pharm. Sci. 1970, 59, 1281-1285.
34. Wold, S.; Eriksson, L. In Chemometric Methods in Molecular Design; van de Waterbeemd, H., Ed., VCH: Weinheim, 1995; pp 309-318.
35. Johnson, C. A.; Westall, J. C. Environ. Sci. Technol. 1990, 24, 1869-1875. Experimental data applied in this paper was provided by J. C. Westall.
36. Tsantili-Kakoulidou, A.; Piperaki, S., Panderi, I; Csizmadia, F; Darvas, F. Quant. Struct-Act. Relat. submitted.
37. Mayer, J. M.; Testa, B.; van de Waterbeemd, H.; Bornand-Crausaz, A. Eur. J. Med. Chem.-Chim. Ther. 1982, 17, 461-466.
38. Hansch, C.; Leo, A.; Hoekman, D. Exploring QSAR. Hydrophobie, Electronic, and Steric Constants; American Chemical Society: Washington, 1995.
39. El Tayar, N.; Tsai, R. S.; Carrupt, P. A.; Testa, B. J. Chem. Soc. Perkin Trans 2 1992, 79-84.
40. Akamatsu, M.; Yoshida, Y.; Nakamura, H.; Asao, M.; Iwamura, H.; Fujita, T. Quant. Struct. Act. Relat. 1989, 8, 195-203.
41. Part 2, Tsantili-Kakoulidou, A.; Panderi, I; Csizmadia, F; Darvas, F. J. Pharm. Sci. Submitted.
42. Perez-Soler R.; Priebe W. Cancer Res. 1990, 50, 4260-4266.
43. Zou, Y.; Ling, Y. H.; Van, N. T.; Priebe, W.; Perez-Soler, R. Cancer Res. 1994, 54, 1479-1484.
44. Wasan, K. M.; Kwong, M. Pharmacol. Toxicol., 1997 In press.
45. Wasan, K. M.; Morton, R. E. Pharm. Res. 1996, 13, 462-468.
46. Vitols, S.; Angelin, B.; Ericsson, S.; Gahrton, G.; Juliusson, G.; Masquelier, M.; Paul, C.; Peterson, C.; Rudling, M.; Soderberg-Reid, K.; Tidefelt, U. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 2598-2602
47. Ling, Y.; Priebe, W.; Yang, L. Y.; Burke, T. G.; Pommier, P.; Perez-Soler, R. Cancer Res. 1993, 53, 1583-1589.
48. Zou, Y.; Proebe, W.; Ling, Y.; Perez-Soler, R. Cancer Chemother. Pharmacol. 1993, 32, 190-196.
49. Havel, R. J.; Eder, H. A.; Bragdon, J. H. J. Clin. Invest. 1955, 34, 1345-1353.
50. Peterson, G. L. Anal. Biochem. 1977, 83, 346-356.
51. Harris, W. S.; Rayfold, A. Lipids 1990, 25, 341-343.
52. Hamilton, R. L.; Williams, M. C.; Fielding, C. J.; Havel, R. J. J. Clin. Invest. 1976, 58, 667-680.
53. Hamilton, R. L.; Havel, R. J.; Kane, J. P.; Blaurock, A. E.; Sata, T. Science (Wash. D.C.) 1971, 172, 475-478.
54. Miyamoto, V. K.; Stoeckenius, W. J. Membr. Biol. 1971, 4, 252-269.
55. Yang, C. Y.; Manoogian, D.; Pao, Q.; et al. J. Biol. Chem. 1988, 262, 3086-3091.
56. Wasan, K. M.; Brazeau, G. A.; Keyhani A.; Hayman, A. C.; Lopez-Berestein, G. Antimicrob. Agents Chemother. 1993, 37, 246-250.
57. Wasan, K. M. J. Pharmacol. Toxicol. Methods 1996, 36, 1-11.